Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with chronic lymphocytic leukemia

Bendamustine has shown a favorable safety profile when included in chemotherapy regimens for several types of lymphoma, including chronic lymphocytic leukemia (CLL). This study investigated the long-term effect of adding bendamustine to a conditioning regimen on survival, rate of engraftment, immune...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Khouri, IF, Sui, D, Jabbour, EJ, Samuels, BI, Turturro, F, Alatrash, G, Anderlini, P, Ahmed, S, Oran, B, Ciurea, SO, Marin, D, Olson, A, Patel, KK, Popat, UR, Ledesma, C, Kadia, TM, Ferrajoli, A, Burger, JA, Jorgensen, JL, Medeiros, LJ, Bassett, RL, Gulbis, AM
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849052/
https://ncbi.nlm.nih.gov/pubmed/27595282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados